type in your search and press enter
You May Also Like
Athenex Announces Initiation of an Oral Eribulin Investigational New Drug Development Program for Oncology Indications
Athenex has developed a novel synthetic method for Eribulin with an excellent purity profileAthenex ...
Adaptimmune Presents Detailed Safety Update from Ongoing MAGE-A10 Pilot Studies at ASCO
- Acceptable safety profile with no evidence of off-target toxicity in 100 million cell ...
109 Healthcare Groups Urge Congress to Immediately Reverse CMS Policy Linking Physician Payment Adjustments to Part B Drug Costs
Washington, DC, Jan. 18, 2018 (GLOBE NEWSWIRE) -- More than 100 of the nation’s ...
